These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 15956542)

  • 1. Compartmentalized human immunodeficiency virus type 1 present in cerebrospinal fluid is produced by short-lived cells.
    Harrington PR; Haas DW; Ritola K; Swanstrom R
    J Virol; 2005 Jul; 79(13):7959-66. PubMed ID: 15956542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compartmentalized human immunodeficiency virus type 1 originates from long-lived cells in some subjects with HIV-1-associated dementia.
    Schnell G; Spudich S; Harrington P; Price RW; Swanstrom R
    PLoS Pathog; 2009 Apr; 5(4):e1000395. PubMed ID: 19390619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 replication in the central nervous system occurs in two distinct cell types.
    Schnell G; Joseph S; Spudich S; Price RW; Swanstrom R
    PLoS Pathog; 2011 Oct; 7(10):e1002286. PubMed ID: 22007152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compartmentalized replication of R5 T cell-tropic HIV-1 in the central nervous system early in the course of infection.
    Sturdevant CB; Joseph SB; Schnell G; Price RW; Swanstrom R; Spudich S
    PLoS Pathog; 2015 Mar; 11(3):e1004720. PubMed ID: 25811757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compartmentalization and clonal amplification of HIV-1 variants in the cerebrospinal fluid during primary infection.
    Schnell G; Price RW; Swanstrom R; Spudich S
    J Virol; 2010 Mar; 84(5):2395-407. PubMed ID: 20015984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy.
    Strain MC; Letendre S; Pillai SK; Russell T; Ignacio CC; Günthard HF; Good B; Smith DM; Wolinsky SM; Furtado M; Marquie-Beck J; Durelle J; Grant I; Richman DD; Marcotte T; McCutchan JA; Ellis RJ; Wong JK
    J Virol; 2005 Feb; 79(3):1772-88. PubMed ID: 15650202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased human immunodeficiency virus type 1 (HIV-1) env compartmentalization in the presence of HIV-1-associated dementia.
    Ritola K; Robertson K; Fiscus SA; Hall C; Swanstrom R
    J Virol; 2005 Aug; 79(16):10830-4. PubMed ID: 16051875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics of simian immunodeficiency virus populations in blood and cerebrospinal fluid over the full course of infection.
    Harrington PR; Connell MJ; Meeker RB; Johnson PR; Swanstrom R
    J Infect Dis; 2007 Oct; 196(7):1058-67. PubMed ID: 17763329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Immunodeficiency Virus Type 1 RNA Detected in the Central Nervous System (CNS) After Years of Suppressive Antiretroviral Therapy Can Originate from a Replicating CNS Reservoir or Clonally Expanded Cells.
    Joseph SB; Kincer LP; Bowman NM; Evans C; Vinikoor MJ; Lippincott CK; Gisslén M; Spudich S; Menezes P; Robertson K; Archin N; Kashuba A; Eron JJ; Price RW; Swanstrom R
    Clin Infect Dis; 2019 Sep; 69(8):1345-1352. PubMed ID: 30561541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid mononuclear cell counts influence CSF HIV-1 RNA levels.
    Martin C; Albert J; Hansson P; Pehrsson P; Link H; Sönnerborg A
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Mar; 17(3):214-9. PubMed ID: 9495220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective and anti-human immunodeficiency virus activity of minocycline.
    Zink MC; Uhrlaub J; DeWitt J; Voelker T; Bullock B; Mankowski J; Tarwater P; Clements J; Barber S
    JAMA; 2005 Apr; 293(16):2003-11. PubMed ID: 15855434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid CD4+ T cell infection in humans and macaques during acute HIV-1 and SHIV infection.
    Sharma V; Creegan M; Tokarev A; Hsu D; Slike BM; Sacdalan C; Chan P; Spudich S; Ananworanich J; Eller MA; Krebs SJ; Vasan S; Bolton DL;
    PLoS Pathog; 2021 Dec; 17(12):e1010105. PubMed ID: 34874976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantifying HIV-1 proviral DNA using the polymerase chain reaction on cerebrospinal fluid and blood of seropositive individuals with and without neurologic abnormalities.
    Schmid P; Conrad A; Syndulko K; Singer EJ; Handley D; Li X; Tao G; Fahy-Chandon B; Tourtellotte WW
    J Acquir Immune Defic Syndr (1988); 1994 Aug; 7(8):777-88. PubMed ID: 7912728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantifying HIV-1 RNA using the polymerase chain reaction on cerebrospinal fluid and serum of seropositive individuals with and without neurologic abnormalities.
    Conrad AJ; Schmid P; Syndulko K; Singer EJ; Nagra RM; Russell JJ; Tourtellotte WW
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(4):425-35. PubMed ID: 7583438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus.
    Kramer-Hämmerle S; Rothenaigner I; Wolff H; Bell JE; Brack-Werner R
    Virus Res; 2005 Aug; 111(2):194-213. PubMed ID: 15885841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What can characterization of cerebrospinal fluid escape populations teach us about viral reservoirs in the central nervous system?
    Joseph SB; Trunfio M; Kincer LP; Calcagno A; Price RW
    AIDS; 2019 Dec; 33 Suppl 2():S171-S179. PubMed ID: 31790378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group.
    Ellis RJ; Hsia K; Spector SA; Nelson JA; Heaton RK; Wallace MR; Abramson I; Atkinson JH; Grant I; McCutchan JA
    Ann Neurol; 1997 Nov; 42(5):679-88. PubMed ID: 9392566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 chemokine coreceptor utilization in paired cerebrospinal fluid and plasma samples: a survey of subjects with viremia.
    Spudich SS; Huang W; Nilsson AC; Petropoulos CJ; Liegler TJ; Whitcomb JM; Price RW
    J Infect Dis; 2005 Mar; 191(6):890-8. PubMed ID: 15717264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell membrane proteins and quasispecies compartmentalization of CSF and plasma HIV-1 from aids patients with neurological disorders.
    Abbate I; Cappiello G; Longo R; Ursitti A; Spanò A; Calcaterra S; Dianzani F; Antinori A; Capobianchi MR
    Infect Genet Evol; 2005 Apr; 5(3):247-53. PubMed ID: 15737916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain.
    McArthur JC; McClernon DR; Cronin MF; Nance-Sproson TE; Saah AJ; St Clair M; Lanier ER
    Ann Neurol; 1997 Nov; 42(5):689-98. PubMed ID: 9392567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.